This inventor holds 1 USPTO granted patent. Top assignees: Mitsubishi Tanabe Pharma Corporation, Osaka University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023
Title: Hiroko Wada: Innovator in Lysophosphatidic Acid Derivatives
Introduction
Hiroko Wada is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on lysophosphatidic acid derivatives. Her research focuses on developing compounds that can act as specific agonists for LPA4 receptors, which are crucial in various medical applications.
Latest Patents
Hiroko Wada holds a patent for a novel lysophosphatidic acid derivative. This invention aims to provide a compound that acts as a specific agonist for LPA4 receptors. The pharmaceutical composition containing this compound is designed for the prophylaxis and treatment of diseases associated with angiogenesis abnormalities and vascular disorders. The patent highlights the potential of this derivative in addressing significant health issues.
Career Highlights
Throughout her career, Hiroko Wada has worked with notable organizations, including Mitsubishi Tanabe Pharma Corporation and Osaka University. Her experience in these institutions has allowed her to advance her research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Hiroko has collaborated with talented individuals in her field, including Maiko Hamada and Yuki Arai. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Hiroko Wada's work in the field of lysophosphatidic acid derivatives showcases her dedication to advancing medical science. Her innovative approach and collaborations have the potential to lead to significant breakthroughs in the treatment of vascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile